nnn

An overview of the current market landscape, featuring a comprehensive list of over 150 active contract services / technology providers, and a detailed analysis based on a number of parameters.

Growing at an annualized rate of over 20%, the cell therapy manufacturing market is estimated to reach close to USD 10 Billion by 2030, claims Roots Analysis.

The "Gene Therapy Market, 2015-2025" report provides an extensive study on the marketed and pipeline gene therapies.

The 'Oral Oncolytics Series: Leukemia, 2014 - 2024' report provides an extensive study of the market of oral targeted leukemia drugs.

The 'Targeted Protein Degradation Market: Focus on Technology Platforms and Therapeutics, 2020-2030' report features an extensive study of the current market landscape.

The 'Novel Clinical Trial Service Providers: Focus on Real World Data Based Trial Services, Virtual Trials, Adaptive, Umbrella and Basket Design.

The approval of KYMRIAH®, YESCARTA®, Alofisel® and Zyntelgo® has increased the interest of pharma stakeholders in cell therapies; further, owing to the technical challenges in this field.